SCHEMBL7780679

SCHEMBL7780679

Cc1ccccc1-c1c(-c2ccc(S(N)(=O)=O)cc2)n[nH]c1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 9/20 0.53
CA12 O43570 2/20 0.53
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA9 Q16790 2/20 0.53
PTGS1 P23219 6/20 0.47
PTGS2 P35354 6/20 0.47
MT-CO2 P00403 1/20 0.42
LMNA P02545 1/20 0.42
CA3 P07451 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
ADRA2B P18089 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
SLC6A2 P23975 1/20 0.42
PDE4A P27815 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779471 0.89 PTGS2 (0.46) LRRK2PTGS1PTGS2ABCC8KCNJ11
SCHEMBL7780666 0.87 LRRK2 (0.54) LRRK2PTGS1PTGS2MAP2K7MAP2K4
SCHEMBL7780581 0.86 LRRK2 (0.52) LRRK2CA12CA1CA2CA9
SCHEMBL7778095 0.86 LRRK2 (0.53) LRRK2CA1CA2PTGS1PTGS2
SCHEMBL7777717 0.85 MAP2K7 (0.53) LRRK2PTGS1PTGS2MAP2K7MAP2K4
SCHEMBL7773326 0.84 LRRK2 (0.68) LRRK2CA12CA1CA2CA9
SCHEMBL8630119 0.83 MAPT (0.45) LRRK2CA12CA1CA2CA9
SCHEMBL7777620 0.83 LRRK2 (0.60) LRRK2CA12CA1CA2CA9
SCHEMBL7780622 0.82 LRRK2 (0.57) LRRK2PTGS1PTGS2MAP2K7MAP2K4
SCHEMBL7779616 0.81 LRRK2 (0.64) LRRK2CA1CA2PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed